|
Market Closed -
Hong Kong S.E.
12:08:06 09/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.165 HKD | -0.16% |
|
-0.24% | +16.98% |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| 08-31 | Cstone Pharmaceuticals Provides Updates on Cs2009 and Pipeline 2.0 Clinical Trials and Product Portfolio | CI |
| Market Cap | 8.43B 9.84B 1.26B 1.08B 1.02B 927M 1.73B 119B 1.74B 12.03B 4.65B 60.83B 4.71B 4.61B 194B | P/E 2026 * |
-18.2x | P/E 2027 * | 8.86x |
|---|---|---|---|---|---|
| Enterprise Value | 7.45B 8.7B 1.11B 954M 898M 819M 1.53B 105B 1.54B 10.64B 4.11B 53.77B 4.17B 4.08B 171B | EV / Sales 2026 * |
17.6x | EV / Sales 2027 * | 2.56x |
| Free-Float |
79.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript : CStone Pharmaceuticals
| 1 day | -0.16% | ||
| 1 week | -0.24% | ||
| Current month | +7.22% | ||
| 1 month | +15.34% | ||
| 3 months | +43.37% | ||
| 6 months | -4.86% | ||
| Current year | +16.98% |
| 1 week | 5.85 |  | 6.58 |
| 1 month | 5.05 | | 6.65 |
| Current year | 4.01 | | 10.41 |
| 1 year | 4.01 | | 12.9 |
| 3 years | 0.8 | | 13.15 |
| 5 years | 0.8 | | 13.18 |
| 10 years | 0.8 | | 19.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/06/26 | Other | Chief Executive Officer | 331,000 | 0.0207% | ||
| 12/06/26 | Other | Chairman | 100,000 | 0.0062% | ||
| 03/06/26 | Other | Chief Executive Officer | 105,000 | 0.0066% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.16% | -0.24% | -51.11% | +184.10% | 1.26B | |
| -2.10% | -1.64% | +45.10% | -2.45% | 80.91B | |
| -0.78% | -1.52% | -18.45% | -36.25% | 60.46B | |
| -3.59% | -9.04% | +465.16% | +30.37% | 56.02B | |
| -1.77% | -5.26% | -9.16% | +29.36% | 49.63B | |
| -2.08% | -8.12% | -3.11% | +145.81% | 45.88B | |
| -3.77% | -1.64% | +50.34% | -17.95% | 31.4B | |
| -1.85% | -0.49% | +43.72% | +94.44% | 25.22B | |
| -2.00% | -3.54% | -2.68% | +156.40% | 22.25B | |
| -2.69% | -2.11% | +61.03% | +100.81% | 16.59B | |
| Average | -1.74% | -0.57% | +58.08% | +68.46% | 38.96B | |
| Weighted average by Cap. | -1.70% | -1.41% | +81.03% | +37.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 494M 63.05M 54.21M 51M 46.54M 86.85M 5.98B 87.3M 604M 234M 3.06B 237M 232M 9.72B | 1.72B 2.01B 257M 221M 208M 189M 353M 24.33B 355M 2.46B 951M 12.43B 964M 943M 39.57B |
| Net income | -384M -448M -57.15M -49.13M -46.22M -42.18M -78.72M -5.42B -79.13M -548M -212M -2.77B -215M -210M -8.81B | 680M 795M 101M 87.17M 82.01M 74.84M 140M 9.61B 140M 972M 376M 4.91B 381M 372M 15.63B |
| Net Debt | -978M -1.14B -146M -125M -118M -108M -201M -13.81B -202M -1.4B -540M -7.06B -547M -535M -22.46B | -4.02B -4.7B -599M -515M -485M -442M -826M -56.82B -830M -5.74B -2.22B -29.04B -2.25B -2.2B -92.42B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | HK$6.165 | -0.16% | 24,703,000 |
| 08/09/26 | HK$6.175 | +1.73% | 20,020,500 |
| 07/09/26 | HK$6.070 | -1.94% | 38,957,300 |
| 04/09/26 | HK$6.190 | +0.16% | 8,773,345 |
| 03/09/26 | HK$6.180 | 0.00% | 5,589,302 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
Select your edition
All financial news and data tailored to specific country editions
